Evidence map›Paper›PMID 21467194›Full record

ArticleEndocrinology2011

Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.

Noriko Suda, Hirotaka Shibata, Isao Kurihara, Yayoi Ikeda, Sakiko Kobayashi, Kenichi Yokota, Ayano Murai-Takeda, Ken Nakagawa, Mototsugu Oya, Masaru Murai and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Noriko SudaDepartment of Internal Medicine, School of Medicine, Keio University, Shinjujku-ku, Tokyo 160-8582, Japan.
Hirotaka Shibata
Isao Kurihara
Yayoi Ikeda
Sakiko Kobayashi
Kenichi Yokota
Ayano Murai-Takeda
Ken Nakagawa
Mototsugu Oya
Masaru Murai
William E Rainey
Takao Saruta
Hiroshi Itoh
Keio University · JPAugusta University · USYokohama City University · JP

Funding

MECHANISMS LEADING TO ADRENAL ZONATIONR01DK043140 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI William E Rainey · 1999 to 2026
$7.2M
MECHANISMS LEADING TO ADRENAL ZONATIONR29DK043140 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RAINEY, WILLIAM E · 1994 to 1998
–
NIDDK NIH HHS DK43140NIDDK NIH HHS R01 DK043140
6 · The paper itself

Abstract

Steroidogenic factor-1 (SF-1) is a nuclear orphan receptor, which is essential for adrenal development and regulation of steroidogenic enzyme expression. SF-1 is posttranslationally modified by small ubiquitin-related modifier-1 (SUMO-1), thus mostly resulting in attenuation of transcription. We investigated the role of sumoylation enzymes, Ubc9 and protein inhibitors of activated STAT1 (PIAS1), in SF-1-mediated transcription of steroidogenic enzyme genes in the adrenal cortex. Coimmunoprecipitation assays showed that both Ubc9 and PIAS1 interacted with SF-1. Transient transfection assays in adrenocortical H295R cells showed Ubc9 and PIAS1 potentiated SF-1-mediated transactivation of reporter constructs containing human CYP17, CYP11A1, and CYP11B1 but not CYP11B2 promoters. Reduction of endogenous Ubc9 and PIAS1 by introducing corresponding small interfering RNA significantly reduced endogenous CYP17, CYP11A1, and CYP11B1 mRNA levels, indicating that they normally function as coactivators of SF-1. Wild type and sumoylation-inactive mutants of Ubc9 and PIAS1 can similarly enhance the SF-1-mediated transactivation of the CYP17 gene, indicating that the coactivation potency of Ubc9 and PIAS1 is independent of sumoylation activity. Chromatin immunoprecipitation assays demonstrated that SF-1, Ubc9, and PIAS1 were recruited to an endogenous CYP17 gene promoter in the context of chromatin in vivo. Immunohistochemistry and Western blotting showed that SF-1, Ubc9, and PIAS1 were expressed in the nuclei of the human adrenal cortex. In cortisol-producing adenomas, the expression pattern of SF-1 and Ubc9 were markedly increased, whereas that of PIAS1 was decreased compared with adjacent normal adrenals. These results showed the physiological roles of Ubc9 and PIAS1 as SF-1 coactivators beyond sumoylation enzymes in adrenocortical steroidogenesis and suggested their possible pathophysiological roles in human cortisol-producing adenomas.

Indexed as

Gene Expression Regulation, EnzymologicTranscriptional ActivationAdrenal CortexCell Line, TumorCholesterol Side-Chain Cleavage EnzymeCytochrome P-450 CYP11B2HumansPromoter Regions, GeneticProtein BindingProtein Inhibitors of Activated STATSmall Ubiquitin-Related Modifier ProteinsSteroid 11-beta-HydroxylaseSteroid 17-alpha-HydroxylaseSteroidogenic Factor 1Transcription, GeneticUbiquitin-Conjugating EnzymesCholesterol Side-Chain Cleavage EnzymeCytochrome P-450 CYP11B2NR5A1 protein, humanPIAS1 protein, humanProtein Inhibitors of Activated STATSmall Ubiquitin-Related Modifier ProteinsSteroid 11-beta-HydroxylaseSteroid 17-alpha-HydroxylaseSteroidogenic Factor 1Ubiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9

Identifiers

PMID21467194
PMCPMC3100613
OpenAlexW2047885999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.